Order Entry
United States
ContactUsLinkComponent
pGL4.18[luc2P/Neo] Vector, 20 µg, Promega
pGL4.18[luc2P/Neo] Vector, 20 µg, Promega
Catalog # PAE6731
CAS Number:  
undefined
pGL4.18[luc2P/Neo] Vector, 20 µg, Promega
Catalog # PAE6731
Supplier Number:  E6731
CAS Number:  

Specifications

  • Size:
    20 μg
  • Cat. No.:
    PAE6731
  • Storage temperature:
    –30...–10 °C
  • Supplier no.:
    E6731

Specifications

About this item

The pGL4.17[luc2/Neo] Vector, pGL4.18[luc2P/Neo] and pGL4.19[luc2CP/Neo] Vectors are optimized for expression in mammalian cells. These vectors offer standard and destablized luciferase with neomycin for stable selection.

  • Reporter Vectors That Lack a Promoter and Offer Different Reporter Protein Stabilities and Neomycin Resistance
  • Designed for cloning a putative promoter element for investigation of gene transcription control regions
  • Available with three varieties of engineered firefly luciferase genes: luc2, luc2P or luc2CP
  • Select for stably transfected cells using neomycin (G418)

Promoterless firefly luciferase vectors are designed primarily to accept a putative promoter element for investigation of important regions controlling gene transcription. The promoterless vectors are available with three varieties of engineered firefly luciferase genes: luc2, luc2P or luc2CP. The luc2 gene is engineered to remove most cryptic transcription factor binding sites and improve mammalian expression through codon optimization. The luc2P and luc2CP and RapidResponse genes are luc2 genes appended with degradation sequences to influence the cellular half-life of the luc2 gene. The RapidResponse genes respond more rapidly to stimuli but at the expense of signal intensity. The luc2P (1-hour half-life) gene responds more rapidly than luc2 (3-hour half-life) with moderate signal intensity, and the luc2CP (0.4-hour half-life) responds more quickly with the lowest signal intensity. The promoterlesspGL4.17[luc2/Neo] Vector, pGL4.18[luc2P/Neo] and pGL4.19[luc2CP/Neo] Vectors are available with a selectable marker, neomycin.